Výsledky vyhledávání

Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

Autor: Hundscheid, T., Onland, W., Kooi, E.M.W., Vijlbrief, D.C., Vries, W.B. de, Dijkman, K.P., Kaam, A.H. van, Villamor, E., Kroon, A.A., Visser, R., Mulder-de Tollenaer, S.M., Bisschop, B. de, Dijk, P.H., Avino, D., Hocq, C., Zecic, A., Meeus, M., Baat, T. de, Derriks, F., Henriksen, T.B., Kyng, K.J., Donders, R., Nuytemans, D.H.G.M., Overmeire, B. van, Mulder, A.L., Boode, W.P. de, BeNeDuctus Trial Investigators

Publikováno v: The New England journal of medicine, 388(11), 980-990. Massachussetts Medical Society
New England Journal of Medicine, 388(11), 980-990. MASSACHUSETTS MEDICAL SOCIETY
Hundscheid, T, Onland, W, Kooi, E M W, Vijlbrief, D C, de Vries, W B, Dijkman, K P, van Kaam, A H, Villamor, E, Kroon, A A, Visser, R, Mulder-de Tollenaer, S M, De Bisschop, B, Dijk, P H, Avino, D, Hocq, C, Zecic, A, Meeus, M, de Baat, T, Derriks, F, Henriksen, T B, Kyng, K J, Donders, R, Nuytemans, D H G M, Van Overmeire, B, Mulder, A L, de Boode, W P & BeNeDuctus Trial Investigators 2023, ' Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus ', The New England Journal of Medicine, vol. 388, no. 11, pp. 980-990 . https://doi.org/10.1056/NEJMoa2207418
The New England journal of medicine
Hundscheid, T, Onland, W, Kooi, E M W, Vijlbrief, D C, de Vries, W B, Dijkman, K P, van Kaam, A H, Villamor, E, Kroon, A A, Visser, R, Mulder-de Tollenaer, S M, de Bisschop, B, Dijk, P H, Avino, D, Hocq, C, Zecic, A, Meeus, M, de Baat, T, Derriks, F, Henriksen, T B, Kyng, K J, Donders, R, Nuytemans, D H G M, van Overmeire, B, Mulder, A L & de Boode, W P 2023, ' Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. ', The New England journal of medicine, vol. 388, no. 11, pp. 980-990 . https://doi.org/10.1056/NEJMoa2207418
The New England Journal of Medicine, 388, 980-990
New England Journal of Medicine. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine
The New England Journal of Medicine, 388, 11, pp. 980-990

Contains fulltext : 290809.pdf (Publisher’s version ) (Closed access) BACKGROUND: Cyclooxygenase inhibitors are commonly used in infants with patent ductus arteriosus (PDA), but the benefit of these drugs is uncertain. METHODS: In this multicenter,

Vyhledávací nástroje:

Upřesnit hledání